Cardio Diagnostics Holdings, Inc. Share Price & Technical Analysis
CDIO · $1.61 (+6.62%)
Healthcare / Biotechnology
$1.61
+6.62%
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. The company offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment clinical blood test targeting CHD events, including heart attacks; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disea…
Price chart
Seasonality
May has 2 positive and 3 negative years (last 5 years shown)
-6% return in May, -35% avg return in past 3 year May month.
215% return in 2026, 173% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -46% | 340% | -63% | -10% | -6% | – | – | – | – | – | – | – | 215% |
| 25 | -56% | 7% | -25% | 21% | -69% | -10% | 11% | -5% | 3% | -2% | -29% | -7% | -162% |
| 24 | -13% | -27% | -14% | -51% | 0% | -19% | -20% | -15% | -41% | 25% | 6% | 186% | 18% |
| 23 | -10% | 259% | 15% | -39% | -36% | -20% | 0% | -55% | -38% | -11% | 573% | 26% | 663% |
| 22 | 0% | 0% | 0% | 0% | 0% | 0% | 1% | 0% | 0% | -72% | -21% | -54% | -144% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Downtrend · Neutral
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. The company offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment clinical blood test targeting CHD events, including heart attacks; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform that offers new epigenetic and genetic insights to clinicians prescribing to help improve chronic care management. It also provides CardioInnovate360, a research-use-only solution to support the discovery, development and validation of novel biopharmaceuticals for the assessment and management of cardiovascular diseases; and HeartRisk, a SaaS cardiovascular disease risk intelligence platform. It serves telemedicine providers; provider organizations, such as concierge practices, longevity clinics, and risk-bearing provider organizations; and employer organizations. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is headquartered in Chicago, Illinois.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$5.39M
P/E ratio
—
52W high
$7.91
52W low
$0.97
Volume
46,739
Beta
2.26
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Cardio Diagnostics Holdings, Inc. share price today?
- Cardio Diagnostics Holdings, Inc. (CDIO) last traded around $1.61 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does CDIO have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for CDIO. Download the app for real-time alerts.
- How can I analyze Cardio Diagnostics Holdings, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.